Abstract
The antagonism between Mdm2 and its close homolog Mdm4 (also known as MdmX) and p53 is vital for embryogenesis and organogenesis. Previously, we demonstrated that targeted disruption of Mdm2 in the Hoxb7+ ureteric bud (Ub) lineage, which gives rise to the renal collecting system, causes renal hypodysplasia culminating in perinatal lethality. In this study, we examine the unique role of Mdm4 in establishing the collecting duct system of the murine kidney. Hoxb7Cre driven loss of Mdm4 in the Ub lineage (UbMdm4−/−) disrupts branching morphogenesis and triggers UB cell apoptosis. UbMdm4−/− kidneys exhibit abnormally dilated Ub tips while the medulla is hypoplastic. These structural alterations result in secondary depletion of nephron progenitors and nascent nephrons. As a result, newborn UbMdm4−/− mice have hypo-dysplastic kidneys. Transcriptional profiling revealed downregulation of the Ret-tyrosine kinase pathway components, Gdnf, Wnt11, Sox8, Etv4 and Cxcr4 in the UbMdm4−/− mice relative to controls. Moreover, the expression levels of the canonical Wnt signaling members Axin2 and Wnt9b are downregulated. Mdm4 deletion upregulated p53 activity and p53-target gene expression including Cdkn1a (p21), Gdf15, Ccng1, PERP, and Fas. Germline loss of p53 in UbMdm4−/− mice largely rescues kidney development and terminal differentiation of the collecting duct. We conclude that Mdm4 plays a unique and vital role in Ub branching morphogenesis and collecting system development.
Introduction
The Murine double minute (Mdm) RING domain proteins, Mdm2 and Mdm4 (also known as MdmX), are endogenous antagonists of the tumor suppressor protein p53 modulating its stability and activity throughout embryogenesis while maintaining homeostasis of adult tissues (Moyer et al., 2017)). Germline elimination of Mdm2 or Mdm4 in mice is embryonic lethal as a result of widespread apoptosis and cell growth arrest (Chavez-Reyes et al., 2003; Jones et al., 1995; Migliorini et al., 2002; Montes de Oca Luna et al., 1995; Parant et al., 2001). However, the co-deletion of Trp53 in these germline mutants renders them viable allowing embryogenesis to proceed normally (Migliorini et al., 2002; Parant et al., 2001).
In most tissues Mdm2 and Mdm4 function synergistically to efficiently regulate p53 activity (Tanimura et al., 1999; Wu et al., 1993). Mdm2 acts to ensure the rapid proteosomal turnover of p53 while also restricting its transcriptional activity either by directly binding to p53 or triggering its nuclear export. On the other hand, Mdm4 being deficient in E3 ligase function restricts p53 activity by directly engaging its transactivation domain. Mdm4 however enhances Mdm2 protein’s E3 ubiquitin ligase activity by dimerizing with it. Disabling the E3 ligase function of Mdm2 does not affect the viability of the mouse mutants since it can adequately inhibit p53 transcriptional activity (Tollini et al., 2014). However, the effects of unbridled p53 activity have lethal consequences in mutant mice where Mdm2 is deficient in both E3 ligase function and its ability to dimerize with Mdm4 (Itahana et al., 2007). Similarly, various Mdm4 RING domain mutants that prevent its interaction with Mdm2 also trigger embryonic lethality (Huang et al., 2011). Thus, the two must act coordinately to keep p53 levels and activity in check during early development.
The definitive kidney in mammals, forms from the intermediate mesoderm (IM). A region of specialized mesenchyme called the metanephric mesenchyme (MM) becomes specified within the caudal IM. Signals from the MM induce the formation of the ureteric bud (Ub), an epithelial evagination of the nephric duct (an epithelial chord within the IM extending along the rostral-caudal axis of the embryo) that ultimately invades the MM. Reciprocal signaling between the two tissue lineages supports repeated branching of the Ub to establish the renal collecting duct system and the ureter (Costantini, 2012; Costantini and Kopan, 2010; Little et al., 2010; Little and McMahon, 2012). Simultaneously, in response to signals from the Ub a subset of the MM becomes resolved into the cap mesenchyme, the precursor of all nephrons, and the stroma from which derive smooth muscle cells, mesangial cells and juxtaglomerular renin cells. Renal hypoplasia with or without accompanying dysplasia is encountered when Ub branching morphogenesis is perturbed. This congenital defect predisposes toward hypertension and often culminates in varying degrees of renal failure in both children and adults (Luyckx et al., 2013).
Previous studies in our laboratory established a requirement for Mdm2 in the morphogenesis of the murine metanephric kidney (Hilliard et al., 2011; Hilliard et al., 2014). We found that Mdm2 mediated suppression of p53 is necessary for the formation of renal epithelial tubules of the kidney. Accordingly, the conditional loss of Mdm2 from the ureteric lineage or the cap mesenchyme stabilizes p53 leading to widespread apoptosis and cell cycle arrest leading to impaired development of the respective tissue lineages. In the absence of Mdm2, the ureteric branches showed lower expression of Wnt9b, Lhx1 and Pax2 while the cap mesenchyme cells showed reduced expression of Cited1, Sall1 and Bmp7. The co-deletion of p53 rescued Mdm2-triggered renal hypoplasia stemming from p53 stabilization in both tissue compartments affirming the role of p53 in these phenotypic outcomes (Hilliard et al., 2011; Hilliard et al., 2014).
The current study was undertaken to examine unique roles of Mdm4 in establishing the collecting duct system of the kidney. We found that Mdm4 has a non-redundant role in supporting Ub branching morphogenesis. Furthermore, a genome-wide analysis of gene expression changes following Ub-specific loss of Mdm4 revealed disruption of key signaling pathways in branching morphogenesis. The most prominently affected pathways in the UbMdm4−/− mutants were the GDNF-Ret receptor tyrosine kinase and Wnt-β-catenin. In addition, we found evidence of elevated expression of p53 target genes which included several of its pro-apoptotic mediators. Most (with the exception of a few persisting cysts) of the UbMdm4−/− kidney phenotypes were mitigated in a p53 null background. Thus, the regulation of p53 activity by Mdm4 is required for Ub branching morphogenesis to proceed normally.
Results
UbMdm4−/− mice have renal hypoplasia despite the presence of functional Mdm2
RNA analysis by quantitative RT-PCR revealed that Mdm4 gene expression is high in embryonic kidneys and declines postnatally (Fig. 1A). Attempts to examine the spatial expression of Mdm4 protein immunohistochemically were not successful due to lack of suitable antibodies. To examine the role of Mdm4 in Ub branching, we crossed mice with conditional alleles of Mdm4 (Mdm4f//f) with Hoxb7Cre-eGFP driver mice (Fig. 1B). The progeny developed to term and were recovered at expected Mendelian ratios. Upon gross and histological examination of newborn kidneys, we found that the UbMdm4−/− kidneys were smaller in size (Fig. 1 C–F) and exhibited hypoplasia of the nephrogenic zone (defined as the outermost zone of the kidney cortex containing nascent Ub tips and nephrons but excluding maturing glomeruli or proximal tubules) (Fig. 1 G,H) and the renal medulla (Fig. 1 I,J).
Figure 1. Deletion of Mdm4 from the Ub lineage impairs kidney growth.

(A) Developmental expression of Mdm4 in mouse kidneys assessed by qRT-PCR. (B) Strategy for targeted Mdm4 deletion in Ub lineage. (C, D) Gross view of the urogenital tract showing small kidneys in newborn UbMdm4−/− compared to control UbMdm4+/+ mice. H&E staining of kidney sections showing small overall size (E, F) and thinner nephrogenic zone (G, H) in UbMdm4−/− mice. (I, J) Newborn UbMdm4−/− mice revealed poor medullary development of kidneys by section immunofluorescence staining.
Mdm4 function is required for normal ureteric bud branching morphogenesis
To better characterize the hypoplastic phenotype, we followed the branching potential of UbMdm4−/− kidneys ex vivo. At E12.5, the Ub had branched twice in both UbMdm4+/+ and UbMdm4−/− kidneys (Fig. 2A). We cultured E12.5 UbMdm4+/+ and UbMdm4−/− kidney explants for 72 hours. At the end of culture, the kidneys were fixed and stained for pan cytokeratin (Ub-specific marker) and WT1 (cap mesenchyme and glomerular podocyte marker). The UbMdm4−/− kidneys had an obvious reduction in Ub branching by 24 hrs (Fig. 2A) and cytokeratin/WT1+ structures at 72 hrs compared to UbMdm4+/+ control kidneys (Fig. 2 B, C). Quantitation of Ub tips in E12.5 kidney explants at the end of 72 hr culture revealed a 57% (2.3-fold) reduction in UbMdm4−/− kidneys (number of Ub tips: 24 ± 4.6, n=3) compared to the wild type controls (56 ± 2.2, n=3) (Fig. 2D). Examination of GFP fluorescence from E13.5 to P0 revealed attenuation of branching morphogenesis in UbMdm4−/− as compared to UbMdm4+/− kidneys as early as E13.5 in vivo (Fig. 2 E). Thus, the Ub of mutant kidneys was able to undergo branching past the T-stage but showed deficits in branching as subsequent development progressed.
Figure 2. Embryonic UbMdm4−/− kidneys have impaired branching morphogenesis.

Whole mount phase contrast microscopy (A) and immunofluorescence staining (B–C) of E12.5 metanephric explants cultured for 72 hrs. (D) Bar graph showing Ub tip counts across the different genotypes. (E) GFP immunofluorescence of E11.5, E13.5, E15.5 and P0 metanephroi.
Cell proliferation and survival are important determinants of branching morphogenesis (Dziarmaga et al., 2003; Maretto et al., 2003; Michael and Davies, 2004). Therefore, we examined the cellular basis for the impaired branching morphogenesis seen in the UbMdm4−/− mutants. Examination of apoptosis levels using cleaved Caspase 3 immunostaining revealed significant cell death in the Ub lineage (cytokeratin-positive) of the E13.5 mutant kidneys (7.8-fold elevation, p=0.0009) relative to wild type littermate control kidneys (Fig. 3 A–E). Some cells positive for active caspase 3 showed a luminal distribution similar to UbMdm2−/− mutant kidneys (Hilliard et al., 2011) (Fig. 3D). Co-immunostaining for phosphorylated histone H3-positive G2/M phase cells and pan cytokeratin at E13.5 did not show a significant change in UB cell proliferation (Fig. 3 F–J). Thus, the elevation in apoptosis contributes to impaired Ub branching morphogenesis seen in the mutants.
Figure 3. Increased apoptosis in E13.5 UbMdm4−/− kidneys.

(A–D) UbMdm4+/+ kidneys have foci of apoptotsis (aCaspase-3 positive foci) in the mesenchyme, whereas UbMdm4−/− kidneys show apoptotic cells lining Ub branches (arrows) and in their lumen (arrowheads). (E) Quantitative analysis of Ub cell apoptosis. Each column represents an n of 5. The error bars represent S.E.M values. (F–J) Spatial distribution and quantitation of proliferating cells in Ub branches is similar in UbMdm4+/+ and UbMdm4−/− kidneys. Abbreviation: ns, not significant
Mdm4 loss in the ureteric lineage causes secondary nephrogenesis defects
Since nephron induction depends on reciprocal interactions between the metanephric mesenchyme and Ub compartments, we assessed the effects on Ub-specific deletion of Mdm4 on nephrogenesis. Deficits in Ub branching yielded fewer nascent nephrons (Lef1/Jagged1-positive) in UbMdm4−/− mutants at E14.5-E15.5 (Fig. 4 A–F). Nascent nephron counts were 40% lower in UbMdm4−/− than UbMdm4+/+ kidneys (Fig. 4 E). At this time, when Ub branching is superseded by elongation processes essential for establishing the renal collecting duct system we begin to see cyst-like dilation of the ureteric tips (Fig. 4 F, I, J). The cystic tubules were derived from the ureteric bud lineage (Cytokeratin/E-cadherin positive) (Fig. 4 J, M).
Figure 4. Impaired nephron formation in embryonic UbMdm4−/− kidneys.

Section immunofluorescence staining of Lef1 (A,B) and Jagged1 (C,D) showing reduced number of nascent nephrons in UbMdm4−/− as compared to UbMdm4+/+ kidneys. (E) quantitation of nascent nephron number. (F-M) Abnormally dilated Ub ampullae and collecting ducts (arrowheads in G; squares in I,J,L,M) in UbMdm4−/− kidneys.
Genome-wide profiling of UbMdm4−/− kidneys
In order to determine the differences in gene expression between UbMdm4+/+ and UbMdm4−/− kidneys, we performed a global analysis of gene expression on E14.5 whole kidneys using mouse 4X 44K array from Agilent Technologies. We chose E14.5 for our analyses because of the timing of the onset of the phenotype. A two-color dye-swap strategy was used to compare four wild type and four mutant pools (100ng of total RNA per sample) to minimize bias from signal detection with the Cy3 and Cy5 color channels. Of the 2547 significantly altered genes in our array (p ≤ 0.05), 1627 were upregulated (range +1.2 to +18.3) while 920 were downregulated (range −1.2 to −4.3) (Fig. 5A). Ingenuity Pathway Analysis-aided analysis of our microarray dataset revealed that the biological functions predicted to be impacted could be resolved into the following categories: (1) disease and disorders 48%; (2) organismal injury and abnormality 23%; (3) metabolism and molecular functions 8%; (4) cellular functions 5% and (5) inflammation 5% (Fig. 5 B). Among the highly up-regulated genes are those encoding the translation initiation factor Eif2s3y, RNA helicase Ddx3y, the cell cycle inhibitor p21 (Cdkn1a), the histone H3K4 demethylase Kdm5d, and Growth and differentiation factor 15 (GDF15) (Fig. 5 C). Interestingly, all of these upregulated genes are known p53-target genes. On the other hand, among the highly downregulated genes are immune and RNA binding proteins, the relevance of which to kidney development is unknown (Fig. 5 C).
Figure 5. Microarray-based transcriptional profiling of E14.5 UbMdm4+/+ and UbMdm4−/− kidneys (n=4/group).

(A) Significantly up- and down-regulated genes. (B) IPA aided analysis of disease biological functions affected in UbMdm4−/− kidneys. (C) IPA aided top analysis of most upregulated and downregulated genes in UbMdm4−/− kidneys. (D) Most significantly upregulated and downregulated genes that are highly enriched in Ub (Rutledge et al, 2017). (E) Quantitative RT-PCR of gene expression to validate expression of selected differentially expressed genes.
Loss of Mdm4 impacts Ub tip and stalk networks.
Ret signaling.
Given that branching morphogenesis is disrupted in UbMdm4−/− kidneys, we looked for Ub tip and stalk genes showing a differential expression by comparing our dataset with those published by Rutledge et al (Rutledge et al., 2017). We found 40 genes enriched in the Ub tip that were common to both datasets (Figure 5 D). Of note were Gfrα1 (GDNF/Ret co-receptor), Sox8, Etv4, Wnt11, and Slco4c1 (organic anion transporter) downstream of Ret signaling with established roles in Ub branching morphogenesis, that were significantly downregulated in UbMdm4−/− kidneys. Validation of the microarray results using a few select genes is shown in Fig. 5 E. Moreover, we performed section in situ hybridization of a subset of Ub genes. At E14.5, we found that Wnt9b and Etv4 were downregulated, whereas c-Ret and Emx2 expression remained unchanged (Fig. 6 A–D). At E17.5, c-Ret, Sox8, Wnt11 and Axin2 were downregulated in the Ub tips, while Etv4 remained unchanged (Fig. 6 E–I). Quantitation of Ub tips revealed a significant reduction in Ub tip number at E13.5, E16.5 and E17.5 (Fig. 6 J). We recently identified the transcription factor, p63, a member of the p53 gene family, as a UB tip specific marker expressed transiently during kidney development (El-Dahr et al., 2017). We compared the expression of p63 in UbMdm4+/+ and UbMdm4−/− neonatal kidneys. The expression of p63 was lost in the majority of mutant Ub tips as compared to control kidneys (Fig. 7).
Figure 6. Ub marker expression in UbMdm4+/+ and UbMdm4−/− kidneys.

Section hybridization at E14.5 (A–D) and E17.5 (E–I). (J) Quantitation of UB tips in various age groups.
Figure 7. Loss of p63-positive Ub tip expressing cells in UbMdm4−/− kidneys.

P63, a member of the p53 gene family, labels Ub tip cells after E15.5 in wild-type kidneys (A, C). Expression of p63 appear strong in the few persisting tips in UbMdm4−/− kidneys (B, D) and is preserved in the urothelium (E, F). (G, H) Schematic of p63 expression in Ub tips.
Wnt9b is a paracrine signaling molecule expressed within the Ub stalk. It signals via the β-catenin pathway to promote renewal of the progenitor cap mesenchyme cells (dorsally) and induce differentiation of the PTA (ventrally) (Karner et al., 2011). Since our microarray and qPCR data showed lower levels of Wnt9b transcripts, we compared our dataset with that of Karner et al (Karner et al., 2011) to see if cognate Wnt9b targets within the metanephric mesenchyme are downregulated in our dataset (Table 1). We find that some of the genes downregulated in Wnt9b−/− kidneys and with bona-fide Lef/Tcf binding sites were similarly downregulated in our dataset. These include nephron inducing genes Wnt4, Cdh4, Pax8, Cxcr4, and Lef1. Simultaneously, the expression of a few Wnt9b targets which support renewal of the progenitor cap mesenchyme such as Gpx6 and Itgα8 were upregulated in our dataset. Furthermore, upregulation and downregulation of some of the genes were reminiscent of those reported in Ctnnb1−/− kidneys (Suppl. Tables 1, 2). Therefore, deficiency of Mdm4 targeted to Ub cells alters the transcript levels of key tip and stalk genes critical for branching morphogenesis and nephron specification. Lastly, we performed HALLMARK pathway analysis to determine the enrichment of select gene set pathways associated with the UbMdm4−/− phenotype and found that the top enriched pathways included Epithelial-mesenchymal transition, p53, apoptosis, Wnt-b-catenin, and Notch among others (Suppl. Fig. S-1).
Table1:
Genes altered in both the UbMdm4−/− and the Wnt9b−/− datasets
| Gene Name | Gene Symbol | Agilent | Expr FC | Location | Type(s) |
|---|---|---|---|---|---|
| glial cell derived neurotrophic factor | Gdnf | A_55_P2745662 | −1.65 | Extracellular Space | growth factor |
| cadherin 4 | Cdh4 | A_52_P181943 | −1.36 | Plasma Membrane | other |
| C-X-C motif chemokine receptor 4 | Cxcr4 | A_55_P2745744 | −1.294 | Plasma Membrane | G-protein coupled receptor |
| Wnt family member 4 | Wnt4 | A_66_P139703 | −1.24 | Extracellular Space | cytokine |
| paired box 8 | Pax8 | A_66_P118214 | −1.236 | Nucleus | transcription regulator |
| lymphoid enhancer binding factor 1 | Lef1 | A_55_P2076871 | −1.208 | Nucleus | transcription regulator |
| integrin subunit alpha 8 | Itga8 | A_51_P309920 | 1.227 | Plasma Membrane | other |
| glutathione peroxidase 6 | Gpx6 | A_51_P299149 | 1.279 | Extracellular Space | enzyme |
Ub-specific deletion of Mdm4 activates p53-dependent pathways.
Given that Mdm4 can regulate p53 transactivation function, we looked for transcript level changes in p53 target genes in the whole-mouse genome following Mdm4 deletion from the Ub. Previously, the widely recognized role of p53 as a tumor suppressor largely overshadowed its contribution to development, differentiation, metabolism, autophagy, aging etc. (Kastenhuber and Lowe, 2017). The nuanced nature of developmental phenotypes encountered in p53−/− mice became evident later on against different mouse strain backgrounds and includes reduced survival, exencephaly, craniofacial abnormalities, congenital anomalies of the kidney and urinary tract, lung defects, and/or reduced fertility of female mice (Armstrong et al., 1995; Donehower et al., 1992; Hu et al., 2007; Kaufman et al., 1997; Rinon et al., 2011; Saifudeen et al., 2009; Tateossian et al., 2015). The corollary, where p53 levels and activity are above what is physiologically normal, similarly poses developmental challenges in multiple tissues and organs including the kidney (Hilliard et al., 2011; Hilliard et al., 2014; Moyer et al., 2017). We found that the abrogation of Mdm4 function from the ureteric epithelia increases p53 transactivation. The most significant changes observed were in p53 target genes modulating the cell cycle (Cdkn1a, Ccng1), cellular apoptosis (Fas, Apaf1, Perp, p53INP1), EMT and invasion (snai2 or SLUG, Pai1 or serpine 2), or inflammation (Thbs1, Adgrb1) (Table 2). Absence of Mdm4 in the Ub affects cell survival and cell fate and ultimately branching morphogenesis.
Table 2:
p53 gene targets altered in the Hoxb7Cre-Mdm4 array.
| Symbol | Entrez Gene Name | Expr Fold Change |
|---|---|---|
| CDKN1A | cyclin dependent kinase inhibitor 1A | 10.449 |
| PERP | PERP, TP53 apoptosis effector | 3.473 |
| CCNG1 | cyclin G1 | 2.132 |
| FAS | Fas cell surface death receptor | 1.696 |
| TP53INP1 | tumor protein p53 inducible nuclear protein 1 | 1.629 |
| APAF1 | apoptotic peptidase activating factor 1 | 1.347 |
| PIK3R4 | phosphoinositide-3-kinase regulatory subunit 4 | 1.333 |
| SERPINE2 | serpin family E member 2 | 1.333 |
| ADGRB1 | adhesion G protein-coupled receptor B1 | 1.283 |
| SNAI2 | snail family transcriptional repressor 2 | 1.278 |
| THBS1 | thrombospondin 1 | 1.209 |
| TOPBP1 | topoisomerase (DNA) II binding protein 1 | −1.201 |
| FGFR2 | fibroblast growth factor receptor 2 | −1.207 |
| PIK3C2A | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha | −1.219 |
| CTNNB1 | catenin beta 1 | −1.276 |
| AKT2 | AKT serine/threonine kinase 2 | −1.303 |
| MAPK8 | mitogen-activated protein kinase 8 | −1.35 |
| AKT1 | AKT serine/threonine kinase 1 | −1.391 |
| PIK3R2 | phosphoinositide-3-kinase regulatory subunit 2 | −1.451 |
| RPRM | reprimo, TP53 dependent G2 arrest mediator homolog | −1.603 |
In order to delineate the p53-mediated gene changes specific to the kidney, we compared our dataset to that derived from our previously published p53-Chip sequencing of E15.5 kidneys (Li et al., 2013). We found 464 gene targets shared by the two datasets (Table 3). Of them, the genes pertinent to Ub morphogenesis and differentiation and bound by p53 are Wnt11, Axin2, Ctnnb1, Gja1, Tcf4, Lgr4 Etv4, Ptch1, Calb1, Crlf1 and Pde5a.
Table 3:
A list of select genes common to Mdm4-Hoxb7Cre array and embryonic kidney p53 Chip Seq (Physiol Genomics 45, 948–964).
| p53 chip seq E15.5 | Mdm4flox-Hox7Cre E14.5 | ||||
|---|---|---|---|---|---|
| Symbol | Entrez Gene Name | Fold affinity | Expr Fold Change | Location | Type(s) |
| CDKN1A | cyclin dependent kinase inhibitor 1A | 16 | 10.449 | Nucleus | kinase |
| EDA2R | ectodysplasin A2 receptor | 18 | 3.651 | Plasma Membrane | transmembrane receptor |
| SP6 | Sp6 transcription factor | 20 | 1.832 | Nucleus | transcription regulator |
| KLF13 | Kruppel like factor 13 | 13 | 1.617 | Nucleus | transcription regulator |
| ITGB4 | integrin subunit beta 4 | 17 | 1.514 | Plasma Membrane | transmembrane receptor |
| GPR65 | G protein-coupled receptor 65 | 15 | 1.427 | Plasma Membrane | G-protein coupled receptor |
| KLF4 | Kruppel like factor 4 | 10 | 1.409 | Nucleus | transcription regulator |
| SLIT2 | slit guidance ligand 2 | 19 | 1.36 | Extracellular Space | other |
| MMP19 | matrix metallopeptidase 19 | 25 | 1.329 | Extracellular Space | peptidase |
| CDH6 | cadherin 6 | 20 | 1.324 | Plasma Membrane | other |
| PCDH8 | protocadherin 8 | 23 | 1.296 | Plasma Membrane | other |
| TEAD1 | TEA domain transcription factor 1 | 23 | 1.212 | Nucleus | transcription regulator |
| LHX1 | LIM homeobox 1 | 21 | −1.21 | Nucleus | transcription regulator |
| TCF4 | transcription factor 4 | 19 | −1.234 | Nucleus | transcription regulator |
| LGR4 | leucine rich repeat containing G protein-coupled receptor 4 | 15 | −1.258 | Plasma Membrane | transmembrane receptor |
| CTNNB1 | catenin beta 1 | 29 | −1.276 | Nucleus | transcription regulator |
| AXIN2 | axin 2 | 15 | −1.299 | Cytoplasm | other |
| GJA1 | gap junction protein alpha 1 | 17 | −1.325 | Plasma Membrane | transporter |
| KLF5 | Kruppel like factor 5 | 24 | −1.327 | Nucleus | transcription regulator |
| MAPK8 | mitogen-activated protein kinase 8 | 19 | −1.35 | Cytoplasm | kinase |
| WNT11 | Wnt family member 11 | 18 | −1.351 | Extracellular Space | other |
| CHD7 | chromodomain helicase DNA binding protein 7 | 15 | −1.372 | Nucleus | enzyme |
| AKT1 | AKT serine/threonine kinase 1 | 39 | −1.391 | Cytoplasm | kinase |
| ATP2B2 | ATPase plasma membrane Ca2+ transporting 2 | 15 | −1.425 | Plasma Membrane | transporter |
| RNASEH2A | ribonuclease H2 subunit A | 27 | −1.472 | Nucleus | enzyme |
| GADD45GIP1 | GADD45G interacting protein 1 | 12 | −1.481 | Nucleus | other |
| ETV4 | ETS variant 4 | 13 | −1.496 | Nucleus | transcription regulator |
| PTCH1 | patched 1 | 25 | −1.584 | Plasma Membrane | transmembrane receptor |
| CALB1 | calbindin 1 | 11 | −1.608 | Cytoplasm | other |
| PDE5A | phosphodiesterase 5A | 12 | −1.7 | Cytoplasm | enzyme |
| RUNX2 | runt related transcription factor 2 | 23 | −1.742 | Nucleus | transcription regulator |
| CRLF1 | cytokine receptor like factor 1 | 20 | −1.795 | Extracellular Space | other |
Elimination of p53 function rescues UbMdm4−/− kidney phenotype
Given the strong involvement of p53 regulated genes in the UbMdm4−/− kidney phenotype, we bred UbMdm4−/− mice into a p53 null background. We found that the UbMdm4−/−; Trp53+/+ mice have small kidneys (Fig. 8 A, B, D, E). However, the size and histology of UbMdm4−/−; Trp53−/− kidneys resembles those of control kidneys (Fig. 8 A, C, D, F). The UbMdm4+/−; p53+/+ kidneys show a 15% reduction while the UbMdm4−/− p53+/+ kidneys show a 41% reduction in surface area when compared to control kidneys (Fig. 8 G). The loss of a single allele of Trp53 (UbMdm4−/− p53+/−) brings about a partial rescue (27% reduction in kidney area) while loss of both Trp53 alleles narrows it further to 8% reduction in kidney area relative to control kidneys (Fig. 8 G). Comparison of neonatal UbMdm4+/+; p53+/+, UbMdm4−/−; p53+/+; and Ub Mdm4−/−; p53−/− kidneys by co-immunostaining for Six2 and pan cytokeratin confirms restoration of gross morphology and histological patterning of the medulla and nephron progenitors (Fig. 8 H–J).
Figure 8. Deletion of p53 rescues the renal phenotype of UbMdm4−/− kidneys.

(A–C) Gross morphology and (D–F) H&E-stained sections showing restoration of kidney size and the nephrogenic zone and medulla in UbMdm4−/−; p53−/− kidneys. (G) Quantitative analysis of kidney surface area showing restoration of kidney size in UbMdm4−/−; p53−/− kidneys. (H–J) Section immunofluorescence showing restoration of Six2+ nephron progenitors and cytokeratin+ collecting ducts in UbMdm4−/−; p53−/− kidneys.
To confirm if Wnt-β-catenin signaling downstream of p53 regulation is restored in the kidneys of rescued mice, we performed in situ hybridization for Axin2 a target of canonical Wnt signaling. In the absence of functional p53, the levels of Axin2 are restored in the UbMdm4−/−; p53−/− medulla compared to UbMdm4−/−; p53+/+ kidneys (Fig. 9 A–F). Similarly, in newborn mice the expression of the Wnt-β-catenin nuclear effector Lef1 shows severe downregulation in the Ub and associated nascent nephrons in UbMdm4−/− kidneys but is restored to wild type levels in the p53 null rescued kidneys (Fig. 9 G–I). This is illustrated schematically in Fig. 9 J–L.
Figure 9. Restored Wnt signaling in UbMdm4−/−; p53−/− kidneys.

(A–F) In situ hybridization showing restoration of Axin2 expression in the renal medulla of UbMdm4−/−; p53−/− kidneys. (G–I) Restored expression of Lef1 in Ub and nascent nephrons of UbMdm4−/−; p53−/− kidneys. (J–L) Schematic representation of the findings in G–I.
The extent of rescue on a p53 null background was evident in histological analysis of P20 kidneys from UbMdm4+/+; p53+/+, UbMdm4−/−; p53+/+; and Ub Mdm4−/−; p53−/− mice. The UbMdm4−/− kidneys are severely dysmorphic in gross appearance and have prominent deficits in medullary collecting ducts formation resulting in severe hydronephrosis (Suppl. Fig. S-2). The histology of UbMdm4−/− kidneys in a p53 null background shows restoration of kidney architecture including the outer medulla (Suppl. Fig. S-2).
Discussion
The regulation of p53 is carefully orchestrated during embryonic development, differentiation, and aging (Tyner et al., 2002; Van Nostrand et al., 2017; Van Nostrand et al., 2014). This is exemplified by the p53-dependent embryonic lethal phenotype following the loss of either gene, Mdm2 or Mdm4 (Jones et al., 1995; Montes de Oca Luna et al., 1995; Parant et al., 2001). The p53 antagonists, Mdm2 and Mdm4, despite their homology and similar modular domains function non-redundantly. Notably, Mdm4 regulation of p53 appears to vary with cellular context (Barboza et al., 2008; Maetens et al., 2007; Mancini and Moretti, 2009). Therefore, loss of Mdm4 triggers cell apoptosis in neuronal and intestinal cells but not in cardiomyocytes, erythroid, and smooth muscle cells where the overwhelming response is cell cycle arrest or impaired cellular proliferation (Boesten et al., 2006; Grier et al., 2006; Maetens et al., 2007; Migliorini et al., 2002; Valentin-Vega et al., 2009). Furthermore, the development and morphogenesis of certain organs like the CNS, eye lens, and endocrine component of pancreas require synergistic interactions between Mdm2 and Mdm4 (Francoz et al., 2006; Xiong et al., 2006; Zhang et al., 2017; Zhang et al., 2014).
The aim of this study was threefold. First, we wanted to determine if Mdm4 has a role in supporting Ub branching morphogenesis. Secondly, with the aid of genome-wide transcript analyses of whole mouse kidneys we looked for p53 dependent and independent alterations in gene expression following Mdm4 loss from ureteric epithelia. Lastly, we examined the contribution of p53 to the mutant phenotype by one or two allele loss of p53. We found that the similar to Mdm2 (Hilliard et al., 2014), Mdm4 expression is high in the developing kidney and declines during postnatal maturation. The UbMdm4−/− kidneys are small and hypoplastic with reduced Ub branching morphogenesis. The downregulation of GDNF-Ret and Wnt/β-catenin signaling together with elevation of p53 transactivation function appear to be contributing to the UbMdm4−/− mutant phenotypes. Therefore, like Mdm2, Mdm4 has an independent role in modulating Ub branching. This study did not address whether Mdm2 compensates for lack of Mdm4 as this requires generation and investigation of double Mdm2/Mdm4 mutants.
Changes in the physiological levels of p53 in response to varying degrees of stress have differing outcomes on cell fate (Vousden, 2002; Vousden and Lane, 2007). Under mild stress p53 induces cell cycle arrest allowing for DNA repair to proceed. Conversely, under acute stress p53 triggers senescence or apoptosis of the affected cells. Even mild elevation of p53 levels as encountered with Mdm2-Mdm4 haplo-insufficiency confers a growth disadvantage on cells (Terzian et al., 2007; Zhang et al., 2017). Of the 200 known p53 targets, 105 show changes in expression in our microarray, consistent with the activation of p53.
Several effectors of the GDNF-Ret-Wnt11 auto-regulatory feedback loop are downregulated in our array. The GDNF-Ret receptor tyrosine kinase pathway has a prominent role in ureteric branching and confers Ub tip identity by inducing Vsnl1, Ret, Sox 8/9, Etv4/5, and Wnt11 expression exclusively in the tip domain (Lu et al., 2009; Ola et al., 2011; Reginensi et al., 2011). The UbMdm4−/− kidneys showed downregulation of selective targets _Vsnl1, Sox8, Etv4 and Wnt11, of this pathway.
Ub specific loss of Mdm4 results in the attenuated expression of canonical Wnt pathway molecules. Supporting this notion is the diminished expression of Wnt ligands (Wnt9b, Wnt11, and Wnt4) and effector molecules (Ctnnb1, Tcf4, and Lef1) coupled with upregulation of endogenous inhibitors such as Dkk2 and Sfrp4. Kim et al. (Kim et al., 2011) found that p53 typically represses canonical Wnt targets _ β-catenin, Lef1, Axin2, through the transactivation of miR-34. Thus, the downregulation of Wnt-β catenin signaling is consistent with up regulation of p53 transactivation in our array. In the developing kidney, β-catenin is required to maintain the Ub tip progenitors and loss of its function from the ureteric lineage results in renal agenesis or hypoplasia (Bridgewater et al., 2008; Marose et al., 2008). Thus, downregulation of Wnt signaling would further explain the hypoplastic phenotype encountered upon Mdm4 loss from the Ub lineage.
In conclusion, the repression of p53 function by Mdm4 supports Ub branching morphogenesis and formation of the collecting system. Apart from elevated p53 transactivation, the Ub-specific loss of Mdm4 results in the disruption of major signaling pathways guiding Ub branching. Differential gene analyses revealed suboptimal expression of several of the tip and stalk genes which would explain the aberrant branching phenotype and hypoplastic kidneys. Surprisingly, despite the elevated expression of Cdkn1a the overwhelming p53 response in the UbMdm4−/− kidneys appears to be pro-apoptotic. Comparison of differentiated cell markers within the collecting ducts of neonatal kidneys showed heightened p53 activity in Mdm4 mutant kidneys which disrupts terminal differentiation. Eliminating p53 in these mutants restores Ub branching morphogenesis and collecting duct development.
Materials and Methods
Animals
Animal protocols utilized in this study were in adherence to the guidelines outlined by the Institutional Animal Care and Use Committee in accordance with NIH. The Mdm4 floxed mice (Grier et al., 2006) originally from Dr. G. Lozano, were a gift from Dr. Hua Lu. The Mdm2 floxed mice (01XH9, Dr. Mary Ellen Perry) were initially obtained from the NCI repository (Frederick MD) while the Hoxb7-Egfp-Cre mice (Zhao et al., 2004) were a kind gift from Dr. Carlton Bates. The p53+/− mice (Jacks et al., 1994) obtained from The Jackson Laboratory (Bar Harbor, Maine, USA) were used in our rescue experiments. The specifications for genotyping were outlined by the respective vendors for Mdm2-floxed mice and p53 conventional mutant mice. To distinguish between Mdm4 wild-type and conditional alleles the following primer set was used (Grier et al., 2006):
F3, 5’-GGTGTCCTTGAACTTGCTGTGTAGAA-3’,
E2re, 5’-CTGGGCCGAGGTGGAATGTGATGT-3’
The Cre transgene was genotyped using the following primer pair:
Forward primer: 5’ -ACCAGCCAGCTATCAACTC-3’
Reverse primer: 5’ -TATACGCGTGCTAGCGAAGATCTCCATCTTCCAGCAG-3’
The breeding strategy used involved crossing Hoxb7-Egfp-Cre tg/−; Mdm4 flox/+ male mice to Mdm4 flox/flox (Mdm4fl/fl) female mice. The p53 rescue experiments involved crossing Hoxb7-Egfp-Cretg/−; Mdm4 flox/+; p53+/− males to Mdm4 flox/flox; p53+/− females. For all timed pregnancies, noon of the day on which the vaginal plug was detected was regarded as embryonic day (E) 0.5.
Gross Morphology
All bright field images were captured using the Nikon SMZ100 stereo microscope mounted with a DS-Fi1 camera. The images were processed using NIS Elements software (Nikon, NY, USA).
Histology
Freshly isolated kidneys were rinsed in ice-cold PBS and fixed overnight in 10% buffered formalin (for histology or IF) or 4% PFA/PBS (for section ISH) at 4C. Following serial alcohol dehydration and clearing in Xylene, the samples were embedded in paraffin. Paraffin embedded kidneys were sectioned either at 4 um (for immunofluorescence staining) or 10um (for in situ hybridization detection).
Hematoxylin and Eosin Staining
Routine Hematoxylin and Eosin staining (Richard-Allan Scientific, ThermoFisher Scientific) was performed on age matched wildtype control and mutant kidney sections (4um). The protocol used was the one outlined by the manufacturer. Slides were mounted in Permount (Electron Microscopy Sciences, VWR) mounting media. Images were captured using a Nikon Digital-Sight DS-U3 camera mounted on a Nikon Eclipse Ni Fluorescent Scope. Images were processed using NIS elements (version 4.4) software.
Organ Culture
Ex vivo kidney explants were grown in 6-well tissue culture treated Transwell plates with 24mm membrane inserts (Cat#3450 Corning Inc.) with a pore size of 0.4um. The kidneys were cultured in Advanced DMEM/F-12 medium (Invitrogen) supplemented with 10% fetal calf serum and 1% penicillin streptomycin (10,000 U/ml, ThermoFisher Scientific) at the air-medium interface in 5% CO2 atmosphere at 37°C. To examine ureteric branching morphogenesis the kidney explants were cultured for up to 72 h. Images were captured using an Olympus BX51 fluorescence microscope.
Immunostaining
Clearing and rehydration of paraffin sections (4um) was followed with antigen retrieval (10mM Sodium Citrate, pH 6.0) in a steamer for 45 min. Endogenous peroxidase was quenched by incubating slides in 3% hydrogen peroxide at room temperature. Sections were blocked for 90 min at room temperature in 0.5% blocking reagent (Perkin-Elmer FP1012) in Tris-buffered saline supplemented with 10% normal donkey serum together with unconjugated, monovalent donkey anti-Rabbit Fab (711-007-003 Jackson Immunoresearch laboratories, Inc., PA) and donkey anti-Mouse Fab (715-007-003) fragments at 15 μl/ml each. Primary antibodies used were goat anti-AQP2 (C17, sc-9882, Santa cruz), anti-rabbit Calbindin (ab25085, Abcam), rabbit anti cleaved caspase 3 (Asp 175, Cat# 9661, Cell Signaling), mouse pan Cytokeratin (C2562, Sigma), mouse anti-E-cadherin (610181, BD Biosciences), rabbit phospho-histone H3 (Ser 10) antibody (9701,Cell Signaling), rabbit anti-Jagged1 (H114, Cat# sc-8303, Santa Cruz), rabbit anti-LEF1 (C12A5, Cat #2230, Cell Signaling), mouse anti-p63 (SFI-6, DCS Immunoline), rabbit anti-Six2 (11562-1-AP, Proteintech), goat anti-V-ATPase (B1) (N-20, cat# sc-21206), rabbit anti-V-ATPase (B1/B2) (H-180, sc-20943), rabbit anti-WT1 (C-19:sc-192, Santa Cruz), and DAPI (D1306, Invitrogen).
For secondary detection we used donkey anti-rabbit, donkey anti-mouse, or donkey anti goat antibodies as was required, conjugated to one of the following Alexafluor dyes: Alexa-Fluor555, AlexaFluor488 or AlexaFluor 647 (Molecular Probes, Invitrogen). The Tyramide Signal Amplification (TSA) fluorescence kit (NEL760001KT, Perkin Elmer) was used in instances where the secondary antibody was conjugated to horse radish peroxidase enzyme instead of a fluorophore. The immunofluorescent images were captured with a Zyla/Andor camera mounted on a Nikon Eclipse Ni fluorescent microscope. The confocal images were captured with the aid of the Confocal Nikon eclipse Ti2 scope.
Quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR)
Quantitative qRT-PCR was performed on total RNA isolated from E14.5 kidneys using the RNeasy Mini Kit (Qiagen). Real-time primer-probe mixes were ordered from Applied Biosystems. The assay was done using the Taqman RNA-to-CT 1step kit (4392938; Applied Biosystems, New York, U.S.A). The thermal profile used was as follows: 48°C for 15min, 95°C for 10min and 40 cycles of 95°C for 15s, 55°C for 1 min and 72°C for 1 min. The reactions were performed in triplicate. The relative transcript levels were calculated using the ΔΔCt method with GAPDH as the endogenous normalizing gene. Three independent experiments using total RNA from kidneys of representative genotypes from age-matched litters were used in our assays. The scale bars represent the standard error of mean of average values. P value was calculated using the two-tailed Student’s T test with a probability of 0.05 considered as significant.
| Gene | Primer-Probe |
|---|---|
| Axin2 | Mm00443610_m1 |
| Bax | Mm00432050_m1 |
| Cdkn1a | Mm00432448_m1 |
| Ccng1 | Mm00438084_m1 |
| Emx2 | Mm00550241_m1 |
| Etv4 | Mm00476696_m1 |
| Gapdh VIC_PL | Mm99999915_g1 |
| Gdf15 | Mm00442228_m1 |
| Sox8 | Mm00803422_m1 |
| Wnt9b | Mm01248219_m1 |
| Wnt11 | Mm00437328_m1 |
In situ Hybridization
In situ hybridization protocol used has been previously described (Hilliard et al., 2011). The samples were fixed overnight in 4%PFA/PBS and prepared for paraffin embedding. The samples were sectioned at 10um. Digoxigenin labeled RNA probes were used to bind the endogenous transcripts in situ. Probe binding was detected using anti-Digoxigenin Fab fragments coupled to Alkaline Phosphatase (Roche Diagnostics) and the chromogenic substrate BM purple.
Genome-wide Microarray Analysis
Microarray analysis was performed using Agilent’s ‘Two color Microarray Based Gene Expression Analysis (Agilent G4140–90050). The assay used 100ng of total RNA isolated from E14.5 whole mouse kidney explants (four pools of wild type matched with four pools of mutant samples) using the RNeasy Mini Kit (Qiagen). The quality of RNA samples was assessed on a Bio Analyzer (Agilent 2100, Palo Alto, CA). Fluorescently labeled (Cy3-CTP or Cy5-CTP) cRNA was generated from 100 ng of total RNA using the Low input quick amp labeling protocol from Agilent. The labeled cRNA was hybridized to Agilent’s 4X 44K whole mouse genome microarray slide. The arrays were scanned using a dual-laser DNA microarray scanner (Agilent). To prevent bias from signal detection with different color dyes (Cy5, Cy3), we applied dye-swap strategy to this experiment, in which identical sample pairs were reverse labeled. The data were then extracted by the Feature Extraction 6.1 software (Agilent). Raw data were processed using GeneSpring GX (version 13.0) software. Only genes, showing a significant (P≤0.05) differential change in expression after Benjamini and Hochberg false discovery rate (FDR) correction in the four datasets, were used for further analyses. Additional analysis of the microarray data was completed using the Ingenuity Pathway Analysis (IPA) software (Qiagen, CA). The raw data is deposited in GEO under GSE137994.
Statistical Analysis.
All experiments were performed on 3–4 biological replicates as indicated in the text. Statistical differences were performed using t-test or one-way ANOVA. A p-value <0.05 was considered statistically significant.
Supplementary Material
Fig. S-1 Enrichment Plots of select gene set pathways associated with the mutant phenotype.
Fig. S-2 p53 deletion rescues renal medulla morphogenesis in UbMdm4−/− mutant mice. H&E staining of P20 kidneys showing severe hydronephrosis and compressed atrophied cortex in UbMdm4−/−; p53+/+ kidneys. These defects are largely rescued in UbMdm4−/−; p53−/− kidneys.
Acknowledgments
We thank Yuwen Li (Hayward Genetics Center, Tulane) for assistance in microarray hybridization analysis and the Tulane Renal & Hypertension Center core facilities. We thank Dr. Carl Bates for Hoxb7-Cre-eGFP mice.
Funding
This work is supported by RO1-DK 62550 from the National Institutes of Health.
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Declaration of competing interest
The authors have no competing or financial interests.
References
- Armstrong JF, Kaufman MH, Harrison DJ, Clarke AR, 1995. High-frequency developmental abnormalities in p53-deficient mice. Curr Biol 5, 931–936. [DOI] [PubMed] [Google Scholar]
- Barboza JA, Iwakuma T, Terzian T, El-Naggar AK, Lozano G, 2008. Mdm2 and Mdm4 loss regulates distinct p53 activities. Mol Cancer Res 6, 947–954. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Boesten LS, Zadelaar SM, De Clercq S, Francoz S, van Nieuwkoop A, Biessen EA, Hofmann F, Feil S, Feil R, Jochemsen AG, Zurcher C, Havekes LM, van Vlijmen BJ, Marine JC, 2006. Mdm2, but not Mdm4, protects terminally differentiated smooth muscle cells from p53-mediated caspase-3-independent cell death. Cell Death Differ 13, 2089–2098. [DOI] [PubMed] [Google Scholar]
- Bridgewater D, Cox B, Cain J, Lau A, Athaide V, Gill PS, Kuure S, Sainio K, Rosenblum ND, 2008. Canonical WNT/beta-catenin signaling is required for ureteric branching. Dev Biol 317, 83–94. [DOI] [PubMed] [Google Scholar]
- Chavez-Reyes A, Parant JM, Amelse LL, de Oca Luna RM, Korsmeyer SJ, Lozano G, 2003. Switching mechanisms of cell death in mdm2- and mdm4-null mice by deletion of p53 downstream targets. Cancer Res 63, 8664–8669. [PubMed] [Google Scholar]
- Costantini F, 2012. Genetic controls and cellular behaviors in branching morphogenesis of the renal collecting system. Wiley Interdiscip Rev Dev Biol 1, 693–713. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Costantini F, Kopan R, 2010. Patterning a complex organ: branching morphogenesis and nephron segmentation in kidney development. Dev Cell 18, 698–712. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr., Butel JS, Bradley A, 1992. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215–221. [DOI] [PubMed] [Google Scholar]
- Dziarmaga A, Clark P, Stayner C, Julien JP, Torban E, Goodyer P, Eccles M, 2003. Ureteric bud apoptosis and renal hypoplasia in transgenic PAX2-Bax fetal mice mimics the renal-coloboma syndrome. J Am Soc Nephrol 14, 2767–2774. [DOI] [PubMed] [Google Scholar]
- Francoz S, Froment P, Bogaerts S, De Clercq S, Maetens M, Doumont G, Bellefroid E, Marine JC, 2006. Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo. Proc Natl Acad Sci U S A 103, 3232–3237. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Grier JD, Xiong S, Elizondo-Fraire AC, Parant JM, Lozano G, 2006. Tissue-specific differences of p53 inhibition by Mdm2 and Mdm4. Mol Cell Biol 26, 192–198. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hilliard S, Aboudehen K, Yao X, El-Dahr SS, 2011. Tight regulation of p53 activity by Mdm2 is required for ureteric bud growth and branching. Dev Biol 353, 354–366. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hilliard SA, Yao X, El-Dahr SS, 2014. Mdm2 is required for maintenance of the nephrogenic niche. Dev Biol 387, 1–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hu W, Feng Z, Teresky AK, Levine AJ, 2007. p53 regulates maternal reproduction through LIF. Nature 450, 721–724. [DOI] [PubMed] [Google Scholar]
- Huang L, Yan Z, Liao X, Li Y, Yang J, Wang ZG, Zuo Y, Kawai H, Shadfan M, Ganapathy S, Yuan ZM, 2011. The p53 inhibitors MDM2/MDMX complex is required for control of p53 activity in vivo. Proc Natl Acad Sci U S A 108, 12001–12006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Itahana K, Mao H, Jin A, Itahana Y, Clegg HV, Lindstrom MS, Bhat KP, Godfrey VL, Evan GI, Zhang Y, 2007. Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation. Cancer Cell 12, 355–366. [DOI] [PubMed] [Google Scholar]
- Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT, Weinberg RA, 1994. Tumor spectrum analysis in p53-mutant mice. Curr Biol 4, 1–7. [DOI] [PubMed] [Google Scholar]
- Jones SN, Roe AE, Donehower LA, Bradley A, 1995. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378, 206–208. [DOI] [PubMed] [Google Scholar]
- Karner CM, Das A, Ma Z, Self M, Chen C, Lum L, Oliver G, Carroll TJ, 2011. Canonical Wnt9b signaling balances progenitor cell expansion and differentiation during kidney development. Development 138, 1247–1257. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kastenhuber ER, Lowe SW, 2017. Putting p53 in Context. Cell 170, 1062–1078. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kaufman MH, Kaufman DB, Brune RM, Stark M, Armstrong JF, Clarke AR, 1997. Analysis of fused maxillary incisor dentition in p53-deficient exencephalic mice. J Anat 191 (Pt 1), 57–64. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kim NH, Kim HS, Kim NG, Lee I, Choi HS, Li XY, Kang SE, Cha SY, Ryu JK, Na JM, Park C, Kim K, Lee S, Gumbiner BM, Yook JI, Weiss SJ, 2011. p53 and microRNA-34 are suppressors of canonical Wnt signaling. Sci Signal 4, ra71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Li Y, Liu J, McLaughlin N, Bachvarov D, Saifudeen Z, El-Dahr SS, 2013. Genome-wide analysis of the p53 gene regulatory network in the developing mouse kidney. Physiol Genomics 45, 948–964. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Little M, Georgas K, Pennisi D, Wilkinson L, 2010. Kidney development: two tales of tubulogenesis. Curr Top Dev Biol 90, 193–229. [DOI] [PubMed] [Google Scholar]
- Little MH, McMahon AP, 2012. Mammalian kidney development: principles, progress, and projections. Cold Spring Harb Perspect Biol 4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lu BC, Cebrian C, Chi X, Kuure S, Kuo R, Bates CM, Arber S, Hassell J, MacNeil L, Hoshi M, Jain S, Asai N, Takahashi M, Schmidt-Ott KM, Barasch J, D’Agati V, Costantini F, 2009. Etv4 and Etv5 are required downstream of GDNF and Ret for kidney branching morphogenesis. Nat Genet 41, 1295–1302. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Luyckx VA, Bertram JF, Brenner BM, Fall C, Hoy WE, Ozanne SE, Vikse BE, 2013. Effect of fetal and child health on kidney development and long-term risk of hypertension and kidney disease. Lancet 382, 273–283. [DOI] [PubMed] [Google Scholar]
- Maetens M, Doumont G, Clercq SD, Francoz S, Froment P, Bellefroid E, Klingmuller U, Lozano G, Marine JC, 2007. Distinct roles of Mdm2 and Mdm4 in red cell production. Blood 109, 2630–2633. [DOI] [PubMed] [Google Scholar]
- Mancini F, Moretti F, 2009. Mitochondrial MDM4 (MDMX): an unpredicted role in the p53-mediated intrinsic apoptotic pathway. Cell Cycle 8, 3854–3859. [DOI] [PubMed] [Google Scholar]
- Maretto S, Cordenonsi M, Dupont S, Braghetta P, Broccoli V, Hassan AB, Volpin D, Bressan GM, Piccolo S, 2003. Mapping Wnt/beta-catenin signaling during mouse development and in colorectal tumors. Proc Natl Acad Sci U S A 100, 3299–3304. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Marose TD, Merkel CE, McMahon AP, Carroll TJ, 2008. Beta-catenin is necessary to keep cells of ureteric bud/Wolffian duct epithelium in a precursor state. Dev Biol 314, 112–126. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Michael L, Davies JA, 2004. Pattern and regulation of cell proliferation during murine ureteric bud development. J Anat 204, 241–255. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Migliorini D, Lazzerini Denchi E, Danovi D, Jochemsen A, Capillo M, Gobbi A, Helin K, Pelicci PG, Marine JC, 2002. Mdm4 (Mdmx) regulates p53-induced growth arrest and neuronal cell death during early embryonic mouse development. Mol Cell Biol 22, 5527–5538. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Montes de Oca Luna R, Wagner DS, Lozano G, 1995. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378, 203–206. [DOI] [PubMed] [Google Scholar]
- Moyer SM, Larsson CA, Lozano G, 2017. Mdm proteins: critical regulators of embry ogenesis and homeostasis. J Mol Cell Biol. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ola R, Jakobson M, Kvist J, Perala N, Kuure S, Braunewell KH, Bridgewater D, Rosenblum ND, Chilov D, Immonen T, Sainio K, Sariola H, 2011. The GDNF target Vsnl1 marks the ureteric tip. J Am Soc Nephrol 22, 274–284. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Parant JM, Reinke V, Mims B, Lozano G, 2001. Organization, expression, and localization of the murine mdmx gene and pseudogene. Gene 270, 277–283. [DOI] [PubMed] [Google Scholar]
- Reginensi A, Clarkson M, Neirijnck Y, Lu B, Ohyama T, Groves AK, Sock E, Wegner M, Costantini F, Chaboissier MC, Schedl A, 2011. SOX9 controls epithelial branching by activating RET effector genes during kidney development. Hum Mol Genet 20, 1143–1153. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rinon A, Molchadsky A, Nathan E, Yovel G, Rotter V, Sarig R, Tzahor E, 2011. p53 coordinates cranial neural crest cell growth and epithelial-mesenchymal transition/delamination processes. Development 138, 1827–1838. [DOI] [PubMed] [Google Scholar]
- Rutledge EA, Benazet JD, McMahon AP, 2017. Cellular heterogeneity in the ureteric progenitor niche and distinct profiles of branching morphogenesis in organ development. Development 144, 3177–3188. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Saifudeen Z, Dipp S, Stefkova J, Yao X, Lookabaugh S, El-Dahr SS, 2009. p53 regulates metanephric development. J Am Soc Nephrol 20, 2328–2337. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tanimura S, Ohtsuka S, Mitsui K, Shirouzu K, Yoshimura A, Ohtsubo M, 1999. MDM2 interacts with MDMX through their RING finger domains. FEBS Lett 447, 5–9. [DOI] [PubMed] [Google Scholar]
- Tateossian H, Morse S, Simon MM, Dean CH, Brown SD, 2015. Interactions between the otitis media gene, Fbxo11, and p53 in the mouse embryonic lung. Dis Model Mech 8, 1531–1542. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Terzian T, Wang Y, Van Pelt CS, Box NF, Travis EL, Lozano G, 2007. Haploinsufficiency of Mdm2 and Mdm4 in tumorigenesis and development. Mol Cell Biol 27, 5479–5485. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tollini LA, Jin A, Park J, Zhang Y, 2014. Regulation of p53 by Mdm2 E3 ligase function is dispensable in embryogenesis and development, but essential in response to DNA damage. Cancer Cell 26, 235–247. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tyner SD, Venkatachalam S, Choi J, Jones S, Ghebranious N, Igelmann H, Lu X, Soron G, Cooper B, Brayton C, Park SH, Thompson T, Karsenty G, Bradley A, Donehower LA, 2002. p53 mutant mice that display early ageing-associated phenotypes. Nature 415, 45–53. [DOI] [PubMed] [Google Scholar]
- Valentin-Vega YA, Box N, Terzian T, Lozano G, 2009. Mdm4 loss in the intestinal epithelium leads to compartmentalized cell death but no tissue abnormalities. Differentiation 77, 442–449. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Van Nostrand JL, Bowen ME, Vogel H, Barna M, Attardi LD, 2017. The p53 family members have distinct roles during mammalian embryonic development. Cell Death Differ 24, 575–579. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Van Nostrand JL, Brady CA, Jung H, Fuentes DR, Kozak MM, Johnson TM, Lin CY, Lin CJ, Swiderski DL, Vogel H, Bernstein JA, Attie-Bitach T, Chang CP, Wysocka J, Martin DM, Attardi LD, 2014. Inappropriate p53 activation during development induces features of CHARGE syndrome. Nature 514, 228–232. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vousden KH, 2002. Activation of the p53 tumor suppressor protein. Biochim Biophys Acta 1602, 47–59. [DOI] [PubMed] [Google Scholar]
- Vousden KH, Lane DP, 2007. p53 in health and disease. Nat Rev Mol Cell Biol 8, 275–283. [DOI] [PubMed] [Google Scholar]
- Wu X, Bayle JH, Olson D, Levine AJ, 1993. The p53-mdm-2 autoregulatory feedback loop. Genes Dev 7, 1126–1132. [DOI] [PubMed] [Google Scholar]
- Xiong S, Van Pelt CS, Elizondo-Fraire AC, Liu G, Lozano G, 2006. Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development. Proc Natl Acad Sci U S A 103, 3226–3231. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhang Y, Zeng SX, Hao Q, Lu H, 2017. Monitoring p53 by MDM2 and MDMX is required for endocrine pancreas development and function in a spatio-temporal manner. Dev Biol 423, 34–45. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhang Y, Zhang X, Lu H, 2014. Aberrant activation of p53 due to loss of MDM2 or MDMX causes early lens dysmorphogenesis. Dev Biol 396, 19–30. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhao H, Kegg H, Grady S, Truong HT, Robinson ML, Baum M, Bates CM, 2004. Role of fibroblast growth factor receptors 1 and 2 in the ureteric bud. Dev Biol 276, 403–415. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Fig. S-1 Enrichment Plots of select gene set pathways associated with the mutant phenotype.
Fig. S-2 p53 deletion rescues renal medulla morphogenesis in UbMdm4−/− mutant mice. H&E staining of P20 kidneys showing severe hydronephrosis and compressed atrophied cortex in UbMdm4−/−; p53+/+ kidneys. These defects are largely rescued in UbMdm4−/−; p53−/− kidneys.
